Dechert’s merger control team advises on high-stakes transactions that frequently sit alongside investigations and contentious proceedings, with the team handling matters from HSR analysis and Second Requests through to litigation. The practice spans Washington DC, San Francisco and New York, working closely with European colleagues on cross-border clearance strategies, with particularly strong activity in retail, life sciences and technology-driven transactions. The group is co-chaired by Steven Bizar, based between Philadelphia and New York, and DC-based Mike Cowie, whose work focuses on government merger investigations and litigation matters in the healthcare and life sciences space. James Fishkin is regularly instructed by retail-sector clients, while in San Francisco Russell Cohen focuses on technology-driven transactions, and New York-based Beverly Ang is a go-to for premerger strategy and filings.
Legal 500 Editorial commentary

Accolades

Client satisfaction: Lawyer & team quality
Client satisfaction: Sector knowledge

Testimonials

Collated independently by Legal 500 research team.

  • ‘The team is extremely details, responsive and start with strategy versus just paper pushing. Our three way merger was extremely complex and this required close coordination with the other legal firm.’
  • ‘Jame Fishkin FTC knowledge, as well as EU law was outstanding. For a lay person Jims ability to explain the process was out standing. Jim and the Dechert team managed thier FTC filing just as the new US administration changed over and all the new heads at the FTC were new.’

Key clients

  • Lexmark International, Inc.
  • Albertsons Companies, Inc.
  • Lannett Company
  • Morgan Stanley Capital Partners and its portfolio company Clarity Software Holdings, Inc.
  • Approved Oil Co. of Brooklyn, Inc.
  • CVS Health Corporation
  • Moss Adams LLP
  • Humana
  • OhioHealth
  • Concentra Group Holdings Parent
  • Clarebout Potatoes
  • Tyber Medical LLC

Work highlights

Advised Lexmark International, Inc. and its investors, Ninestar Corporation, PAG Asia Capital, and Shanghai Shouda Investment Centre, in Lexmark’s USD 1.5 billion acquisition by Xerox Holdings Corporation.
Acted for Albertsons in the highest-profile U.S. merger litigation of 2024, defending the company in multiple separate challenges to rival grocery company Kroger’s USD 24.6 billion proposed acquisition of Albertsons.
Advising US-based Lannett Company, one of the largest generic pharmaceutical manufacturers in the United States, on the antitrust aspects of its sale to India-based Aurobindo.
Practice head

Mike Cowie; Steve Bizar

Other key lawyers

ames Fishkin; Brian Hanna; Russell Cohen; Beverly Ang